CAS 182760-06-1 appears in our catalog under these names: Ravuconazole (BMS–207147), Ravuconazole, Ravuconazole/ 99.86% (existing batch purity), Ravuconazole, >98.0%(HPLC)(qNMR), Ravuconazole 98%. Offered by: GLPBio, Chemat Brand, TRC, TargetMol, TCI. Available pack sizes: 1mg, on request, 10mg, 2mg, 5mg, 25mg, 50mg, 100mg.
Ravuconazole is a member of the class of triazoles that is 1-butyl-1H-1,2,4-triazole in which the butyl group is substituted at positions 2, 2, and 3 by hydroxy, 2,4-difluorophenyl, and 4-(p-cyanophenyl)-1,3-thiazol-2-yl groups, respectively (the R,R stereoisomer). It exhibits antifungal activity by inhibition of 14alpha demethylase, an enzyme involved in sterol synthesis, resulting in lysis of the fungal cell wall and fungal cell death. (NCIO4). It has a role as an EC 1.14.14.154 (sterol 14alpha-demethylase) inhibitor, an antileishmanial agent, an ergosterol biosynthesis inhibitor and an antifungal drug. It is a nitrile, a tertiary alcohol, a member of fluorobenzenes, a member of triazoles and a member of 1,3-thiazoles.
Source: ChEBI
| Molecular formula | C22H17F2N5OS |
|---|---|
| Molecular weight | 437.5 g/mol |
| IUPAC name | 4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile |
| InChIKey | OPAHEYNNJWPQPX-RCDICMHDSA-N |
| SMILES | C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)O |
Computed by PubChem (NCBI)